Drug updated on 1/4/2024
| Dosage Form | Injection (intravenous: 300 MBq/mL to 1,900 MBq/mL (8.1 mCi/mL to 51 mCi/mL) of flortaucipir F 18 injection in a multiple-dose vial) |
| Drug Class | Radioactive diagnostic agents |
| Ongoing and Completed Studies | ClinicalTrials.gov |
Indication
- Indicated for positron emission tomography (PET) imaging of the brain to estimate the density and distribution of aggregated tau neurofibrillary tangles (NFTs) in adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease (AD).
Product Monograph / Prescribing Information
| Document Title | Year | Source |
|---|---|---|
| Tauvid (flortaucipir F18) Prescribing Information. | 2022 | Avid Radiopharmaceuticals, Philadelphia, PA |